Envafolimab Antibody

SKU: orb1980728

Description

Envafolimab (ASC 22) is a humanized anti-PD-L1 monoclonal antibody that inhibits the PD-1/PD-L1 pathway to restore antitumor immunity. It is utilized in preclinical and clinical research for various solid tumors, supporting both in vitro mechanistic studies and in vivo efficacy models.

Research Area

Cell Biology, Immunology & Inflammation

Images & Validation

−

Key Properties

−

CAS Number	2102192-68-5
MW	80 kDa
Purity	95.00%
Target	PD-1/PD-L1

Bioactivity

−

In Vitro	Envafolimab can inhibit the growth of gastric cancer cells with low PD-L1 expression by down-regulating DDX20 expression and regulating NFκB/TNF-α signaling pathway. Read more...

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

KN 035, KN035, ASC 22, ASC22

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

PD-1/PD-L1

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols